chrisvoncsefalvay/vaers-outcomes huggingface dataset:
high blood pressure 10 days after receiving second dose on 11Feb2021.  He felt off, and his neck felt weird, and he checked his blood pressure.  His was usually 110/70 and now it was around 165/100.; This is a spontaneous report from a contactable consumer (patient himself). A 75-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, lot number and expiry dates were not provided), via unspecified route of administration, in the left arm, on 01Feb2021 (at the age of 75-year-old), as dose 2, single for COVID-19 immunization. The patient's medical history included pain was stared from unknown dates and unknown if ongoing. Patient did not receive any other vaccinations within four weeks prior to the first administration date of the suspect vaccine. Concomitant medication included meloxicam (strength: 15mg) 15mg once a day by mouth for pain, works really good, taking about 3 years or so. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: solution for injection, lot number and expiry dates were not provided), via unspecified route of administration, on an unknown date (it was 21 days before his second dose) as a single dose for COVID-19 immunization. Patient received second Pfizer dose on 01Feb2021. Patient developed high blood pressure 10 days after receiving second dose on 11Feb2021. He felt off, and his neck felt weird, and he checked his blood pressure. It was usually 110/70 and now it was around 165/100. Patient stated that about 10 days after taking the second shot, he got high blood pressure, states he cannot say if it was related to the vaccine, but has never had high blood pressure in his life, wants to know if other people have experienced this. Patient did go to the doctor and was put on medication, it has not helped much, medication is the generic for Norvasc, amlodipine 5mg, one time a day by mouth. Patient received amlodipine treatment for high blood pressure and amlodipine not helped much. Patient required a physician Office visit for event. The outcome of the event was not recovered.   No follow-up attempts are needed; information about lot/batch number cannot been obtained.
Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021; Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) and POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) in a 39-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Feb-2021 at 10:01 AM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 08-Feb-2021 at 10:01 AM, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) and POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The age of patient was provided as 39.12.  Concomitant products were not provided.  On 08-Feb-2021, Excursion time was 10 AM and 11 AM and temperature was 29 and 35 degrees, total doses given for the day was 30. Condition of vaccine prior to administration was not frozen, vaccine was moved to fridge on 02-Feb-2021, vial was moved to clinic on 08-Feb-2021. 3 vials were sent to clinic. Vaccine BUD date was 04-Mar-2021.  The vials were only punctured right before administration and all doses were drawn from the vial due to high-pace clinic.  Temperature recordings were taken using a brand traceable temperature monitor at every hour.  After administration, the vial was returned to the freezer/refrigerator, or maintained at room temperature.  It was reported that the patient was administered with vaccines that experienced more than 1 temperature excursion during 33 weeks in 2021. The HCP explained that each time a vial was put into a cooler, there was a period of 1 hour or 1 and half hour approximately, when the temperature data logger registered 34 or 35 degree F.  Treatment medications were not reported.
pt recv vax & pt exp severe redness, soreness & swelling in the arm & joint;
Information regarding PREVNAR was received from a healthcare professional regarding a 2-month-old patient who experienced administered improperly stored vaccine at 47 degrees for about 1 hour. The patient received a dose on 14-Aug-2008. The patient was administered improperly stored vaccine at 47 degrees for about 1 hour (medication error) 0n 14-Aug-2008. No additional information was available at the time of this report.
Information has been received from a registered nurse referring to a patient of unknown age and gender. On an unknown date in 2009 the patient was vaccinated with the first dose of GARDASIL (dose, strength, lot # and route were not reported). On 15-MAY-2015 the patient was vaccinated with the second dose of GARDASIL (dose, strength, lot # and route were not reported). No adverse effects were reported. Additional information has been requested.
No reaction, however the third injection was given too soon.  Last injection was in Oct, and there must be a 6 month  span so it was given 3 months early for booster
Known as "Covid Arm" according to the internet, I experienced swelling at the site of the injection that became red, hard and sore. The affected area was about a 3" circle on my upper arm. As of last week (03/10-12/21), these symptoms have pretty much gone away.
Rash on back; This case was reported by a consumer via call center representative and described the occurrence of rash in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced rash. On an unknown date, the outcome of the rash was unknown.   It was unknown if the reporter considered the rash to be related to Shingrix.  Additional case details were reported as follows: The age at vaccination was not reported. The patient received Shingrix and developed a rash on her back. The reporter asked was that a normal reaction to the vaccine.
Information has been received from a physician concerning a 68 year old female with no drug reactions or allergies with hypothyroidism, hypercholesterolaemia and depression who on 04-OCT-2007 was vaccinated intramuscularly with the first dose of PNEUMOVAX 23, (Lot # 657525/0554U). Concomitant therapy SYNTHROID, ZOLOFT, ezetimibe (MSD) and LOVAZA. The physician reported that the patient developed erythema, pain and swelling at the injection site of the left arm after receiving her first dose of PNEUMOVAX 23. The physician examined the patient on 09-OCT-2007 and prescribed warm compresses and TYLENOL. No further details were available. This is case 1 of 2. Additional information has been requested.
Patient came in for second dose of moderna vaccine and instead was mistakenly injected with the Pfizer vaccine.  She felt fine at the time of the vaccination and stayed the recommended monitoring time (15 minutes).  She felt fine when she left a little after 4 PM.
A report has been received from a Health Professional concerning a patient, female subject, who had been receiving FLUMIST (Intranasal). FLUMIST (Intranasal) started on an unknown date. The patient experienced EXPIRED FLUMIST ADMINISTERED. The outcome of the event of EXPIRED FLUMIST ADMINISTERED is unknown. The report was considered to be non-serious. Corrected report 26-feb-2014: Key ingredient of FLUMIST was changed from FLUMIST to Q/LAIV.
Case completed Covid series in March 2021, then was hospitalized for Covid in October 2021
Pt recv vax on 1/5/99; on 1/6/99 pt exp local rx w/ induration from upper arm to elbow, itching, fever (99.6), hard nodule at vax site
This is a verbatim narrative as reported on a website, accessed on 28 July 2011. According to the web site these reports were from FDA VAERS. "FLUMIST problem was reported on Dec 04, 2007. Female patient, child 7 years of age, was vaccinated with FLUMIST on Dec 04, 2007.  "Fever 103 less than 12 hours after FLUMIST administered. Also complained of sore throat, stomach ache, dizziness, headache." None. None Patient recovered."
This spontaneous report as received from a nurse practitioner refers to a female patient currently in her early twenties. The patient's pertinent medical history, concomitant medications and drug allergies were unknown. On an unknown date (reported as "while in her school years"), the patient was vaccinated with GARDASIL (concentration, number of doses, route of administration, lot number and expiration date were unspecified). On an unknown date, the patient had positive test for human papilloma virus. The outcome of the event is unknown.
Itching on left arm; Sore inside mouth; Shingles; This spontaneous case was reported by a consumer and describes the occurrence of HERPES ZOSTER (Shingles), ORAL PAIN (Sore inside mouth) and PRURITUS (Itching on left arm) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Mar-2021, the patient experienced HERPES ZOSTER (Shingles). On 05-Mar-2021, the patient experienced ORAL PAIN (Sore inside mouth). On 07-Mar-2021, the patient experienced PRURITUS (Itching on left arm). At the time of the report, HERPES ZOSTER (Shingles), ORAL PAIN (Sore inside mouth) and PRURITUS (Itching on left arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Patient woke up from his nap with redness surrounding the vaccine area hot to touch and fever of 101.6 progressed to swollen shoulder and upper arm and very stiff. Later that night the area became harder flesh colored with grey tone and a ring of redness around it with pronounced veins traveling from area to neck and chest. Called dr. On call and she advised me to give him motrin and benadryl and left message for patient's dr, and was called back when open of following day scheduled right away to come in and check area.
No adverse event; Vaccine was expired on 30-Mar-2023 and was administered on 02-Apr-2023; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine was expired on 30-Mar-2023 and was administered on 02-Apr-2023) and NO ADVERSE EVENT (No adverse event) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042C22A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 02-Apr-2023, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Apr-2023,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine was expired on 30-Mar-2023 and was administered on 02-Apr-2023). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vaccine was expired on 30-Mar-2023 and was administered on 02-Apr-2023) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Vaccine was expired on 30-Mar-2023 and was administered on 02-Apr-2023).    No concomitant medications were reported. No treatment medications were provided.
Had severe swelling and redness at injection point. Entire left upper arm and curved part of shoulder stuck out about two inches. Area was very sore to the touch. All of my muscles ached and I was completely wore out (fatigued) for three days, My pain increased similar to when I had my back surgery. I did nothing but stay in my recliner for the three days. On the 17th of March when I woke up the swelling and redness had almost totally gone away, my pain became tolerable and the only other change is that I felt nausea for the first 4 to five hours of the day. Having lived thru necrotizing pancreatitis, Kyrle's and cythro cytosis I have a compromised immune system.
loss of vision in left eye; loss of hearing; autoimmune disease; vision issues; balance issues; thyroid issues; This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a currently approximately 77-year-old patient of unknown gender. No information was provided regarding medical history, concurrent conditions, or concomitant medications. On or about 20-NOV-2014, the patient was administered the zoster vaccine live (ZOSTAVAX) (dose, route of administration, anatomical location, lot # and expiration date were not specified) at county health department for the long-term prevention of shingles and zoster-related conditions. Subsequently, on an unspecified date, the patient was treated by providers for the following injuries resulting from the patient's zoster vaccine live (ZOSTAVAX) use: loss of vision in left eye, vision issues, loss of hearing, balance issues, thyroid issues and autoimmune disease. The outcomes of all the events were not reported. The reporter considered all the events to be related to zoster vaccine live (ZOSTAVAX).   Upon internal review, the events of loss of vision in left eye, loss of hearing and autoimmune disease were determined to be medically significant.
Diarrhea; Vomiting; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Diarrhea) and VOMITING (Vomiting) in a 60-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 047B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 29-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Apr-2021, the patient experienced DIARRHOEA (Diarrhea) and VOMITING (Vomiting). At the time of the report, DIARRHOEA (Diarrhea) and VOMITING (Vomiting) outcome was unknown.            Concomitant medication included Diabetes medications.  No treatment medications were reported.
Approximately 36 hours after vaccinations, patient awoke screaming with a 102 F fever. He continued high-pitched screaming for about an hour, then slept 45 minutes, then awoke again screaming. This pattern lasted about 10 hours. In the morning, patient was taken to physician who examined him. Reaction subsided on its own without treatment.
Fever, chills, nausea, vomiting, severe headache, severe muscle pain, joint pain, muscle weakness, extreme fatigue
I was working on this day. We had an emergency patient come in with a deep laceration that our provider had to stitch, as I assisted her. This was around 12:45 pm. This took around 45 min. Our regular scheduled 1:00 pm was the mother of the 1:15 pm and 1:15 pm patient was the mother of the infant. This is why they were all in one room. Patient was here for a nurse visit for immunizations. I was only available due to lunch. After assisting with the laceration I roomed both the 1:00 pm and 1:15 pm patients in same room along with the pediatric patient which was the 1:15 pm patients son. I had already written down the vaccinations that patient needed by looking in his chart and looking at vaccination chart. I drew up two intramuscular vaccinations, PENTACEL, hib and an oral vaccination which was the rotavirus. Gave patient the shots one in each leg and then the oral dose. I then proceeded to go to my desk to document the immunizations. I read the first vial and I realized that one of the intramuscular shots which was supposed to be the Hib was in fact a HPV. I reported this to provider but had to wait for the next day to report it. Spoke with employer first thing on 10/13/15, she contacted state immunization program and they said the only adverse reaction was swollen leg and redness. I contacted the mother to let her know.
GUMS HURT; BACK ACHE; FALL; CHILLS; FEVER; HEADACHE; This spontaneous report received from a patient concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805029, expiry: UNKNOWN) dose was not reported, administered on 13-MAR-2021 for prophylactic vaccination. No concomitant medications were reported. On 13-MAR-2021, the subject experienced chills. On 13-MAR-2021, the subject experienced fever. On 13-MAR-2021, the subject experienced headache. On an unspecified date, the subject experienced gums hurt, back ache, and fall. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from headache, chills, and fever, and the outcome of gums hurt, back ache and fall was not reported. This report was non-serious.
Gave Varicella by mistake, it wasn't needed because I had given Proquad.  No adverse events occurred at this time.
Fatigue on Monday 2/8 evening, Tuesday 2/9- swollen, warm, oval red skin about the size of a tennis ball on upper right arm just under site of injection. Same area was very tender for 24 hours after injection.
-swelling, redness, warmth @ right deltoid for approximately 1 week -feverish for multiple days continues soreness/tenderness/slightly raised for a month after
prescription to start a 2nd series of Shingrix; This case was reported by a pharmacist via call center representative and described the occurrence of product prescribing error in a 71-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   The patient's past medical history included organ transplant (had organ transplant on an unknown date). Previously administered products included Shingrix (completed the series in 2018).   On an unknown date, the patient received Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced product prescribing error. On an unknown date, the outcome of the product prescribing error was unknown.   Additional Information: GSK Receipt Date: 1-Aug-2022 Reporter's Comments: The patient had completed the Shingrix series in 2018 and had a organ transplant. The patient had a prescription to start a 2nd series of Shingrix. The reporter did not know what type of transplant and the patient had not yet received any repeat doses. The reporter consented to follow up. Additional Supportive Information: The patient had a prescription to start a 2nd series of Shingrix, which led to Product prescribing error.
severe local reaction with redness and swelling starting within 18 hours, largely resolved within 5 days but residual pain and tenderness persisting (albeit continuing to resolve) now at 9 days, limited mobility started almost immediately and resolved over approx 5 day systemic symptoms - nausea, fever, chills, anorexia, fatigue, dizziness, starting with 8 hours and lasting 72 hours
10 days after vaccine was given client called to report that the evening after receiving Tdap vaccine she began itching on face, head and arms.  A few days later she noticed small bumps on arms, face, neck, stomach and hairline.  Stated she had swelling of ears later in the evening of the injection.
Pt states approximately 3 hours after receiving vaccine, developed severe diarrhea. 2 1/2 hours later developed vomiting, chills, temp and headache. Did not recover until following afternoon approx. 12 hrs later. Advised to notifiy PMD.
Tested Positive for COVID; Tested Positive for COVID; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 54-year-old female patient received BNT162b2 (BNT162B2), on 01Oct2021 as dose 1, single (Batch/Lot number: unknown) and in Nov2021 as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Eosinophilia" (ongoing). Concomitant medication(s) included: ZYRTEC-D (ongoing). The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 23Jan2023, outcome "unknown" and all described as "Tested Positive for COVID". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (23Jan2023) Positive. Therapeutic measures were taken as a result of drug ineffective, covid-19.  Clinical course:She reported this is her first time to have COVID. she was diagnosed on Saturday, later clarified as her symptoms started on Saturday, but she tested Positive for COVID on Monday night and she began Paxlovid on Monday night. she has taken 4 doses, but she didn't take the dose last night. She stated she has a Pork and Red Meat Allergy, and it caused a thickness in her tongue and throat, caller stated last night something with her tongue and throat triggered it. she is already taking Zyrtec D. Caller stated due to this, she chose not to take the Paxlovid last night or this morning. she was also having abdominal pain in her right side that was uncomfortable where she has scar tissue from where her gall bladder was removed. She stated that hasn't bothered her in a long time. last night with her tongue and throat reaction she was looking as if she couldn't breathe, it was almost like a histamine reaction. she had a Metallic Taste in her mouth. The first time it was really bad and then it got better. she drank a lot of water. Took the Paxlovid with Sherbet Ice Cream and asked how long until it will be out of her system. She stated when she picked up the Paxlovid, she asked if it was made from pigs, pork or something with red meat to make the meds with and the Pharmacist couldn't tell if it was. Caller stated when she did the Pfizer COVID 19 Vaccine in 2021, she had a pretty good reaction to it and her doctor said she couldn't take anymore or do any Booster. she thought that she has already reported it. She thought the first one of 01Oct2021 and the second was 4 weeks later on 01Nov2021 or 02Nov2021. She is one of those people where if it happens it is going to happen with her. Caller stated the first dose they did in the doctor's office, and they had to get the crash cart out. States the 2nd was in the doctor's office with her husband. It takes the full 30 minutes before she has a reaction. Description of complaint: Tested Positive for COVID after receiving 2 doses of the COVID 19 Vaccine. Product strength and count size dispensed: Not Provided.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
approx 1 1/2 wk p/vax pt began to exp mild vertigo; this cont until today; pt reports never had prev epsidoe of vertigo priot to the episode;